The role of pelvic exenteration in the management of recurrent rectal cancer

American Journal of Surgery

Volumn 186, Issue 6, 2003, Pages 660-664

  Kakuda, James T ^a   Lamont, Jeffrey P ^a   Chu, David Z J ^a   Paz, I Benjamin ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Morbidity; Palliation; Pelvic exenteration; Quality of life; Rectal cancer; Recurrent rectal cancer

Indexed keywords

ADULT; AGED; ARTERY INJURY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLON PERFORATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE EXACERBATION; FEMALE; FISTULA; HERNIA; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; LUNG EMBOLISM; MALE; MORTALITY; PALLIATIVE THERAPY; PELVIS ABSCESS; PELVIS EXENTERATION; PRIORITY JOURNAL; RECTUM CANCER; RECURRENT CANCER; RETROSPECTIVE STUDY; REVIEW; SMALL INTESTINE OBSTRUCTION; STROKE; URINARY TRACT INFECTION; URINE INCONTINENCE; VEIN INJURY; WOUND INFECTION;

EID: 0347481484     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2003.08.011     Document Type: Article

References (13)

1. Heald R.J., Moran B.J., Ryall R.D., et al. Rectal cancer the Basingstoke experience of total mesorectal excision, 1978-1997 . Arch Surg. 133:1998;894-899.
2. Rinnert-Gongora S., Tartter P.I. Multivariate analysis of recurrence after anterior resection for colorectal carcinoma. Am J Surg. 157:1989;573-576.
3. Pahlman L., Glimelius B. Local recurrences after surgical treatment for rectal carcinoma. Acta Chir Scand. 150:1984;331-335.
4. Carlsson U., Lasson A., Ekelund G. Recurrence rates after curative surgery for rectal carcinoma, with special reference to their accuracy. Dis Colon Rectum. 30:1987;431-434.
5. Arnott S.J. The value of combined 5-flurouracil and x-ray therapy in the palliation of locally recurrent and inoperable rectal carcinoma. Clin Radiol. 26:1975;177-182.
6. Wanebo H.J., Gaker D.L., Whitehill R., et al. Pelvic recurrence of rectal cancer options for curative resection . Ann Surg. 205:1987;482-494.
7. Yeung R.S., Moffat F.L., Falk R.E. Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma. Cancer. 72:1993;1853-1858.
8. Salo J.C., Paty P.B., Guillem J., et al. Surgical salvage of recurrent rectal carcinoma after curative resection a 10-year experience . Ann Surg Oncol. 6:1999;171-177.
9. Taylor W.E., Donohue J.H., Gunderson L.L., et al. The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Ann Surg Oncol. 9:2002;177-185.
10. Brophy P.F., Hoffman J.P., Eisenberg B.L. The role of palliative pelvic exenteration. Am J Surg. 167:1994;386-390.
11. Yeung R.S., Moffat F.L., Falk R.E. Pelvic exenteration for recurrent colorectal carcinoma a review . Cancer Invest. 12:1994;176-188.
12. Hafner G.H., Herrera L., Petrelli N.J. Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma. Ann Surg. 215:1992;63-67.
13. Lopez M.J., Standiford S.B., Skibba J.L. Total pelvic exenteration a 50-year experience at the Ellis Fischel Cancer Center . Arch Surg. 129:1994;390-395.